Network Pharmacology-Based Analysis of the Pharmacological Mechanisms of Aloperine on Cardiovascular Disease

Abstract EN

Background.

Aloperine is an active component of Sophora alopecuroides Linn, which has been extensively applied for the treatment of cardiovascular disease (CVD).

However, our current understanding of the molecular mechanisms supporting the effects of aloperine on CVD remains unclear.

Methods.

Systematic network pharmacology was conducted to provide testable hypotheses about pharmacological mechanisms of the protective effects of aloperine against CVD.

Detailed structure was obtained from Traditional Chinese Medicines Integrated Database (TCMID).

Target genes of aloperine against CVD were collected from SwissTargetPrediction, DrugBank database, and Online Mendelian Inheritance in Man (OMIM) database.

Gene Ontology (GO) enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway performance, and network construction were adopted to explore common target genes.

Results.

Our findings showed that 25 candidate targets were the interacting genes between aloperine and CVD.

GO analysis revealed biological process, cellular component, and molecular function of these target genes.

More importantly, the majority of enrichment pathways was found to be highly associated with the nitrogen metabolism by KEGG analysis.

Core genes particularly in nitrogen metabolism pathway including carbonic anhydrase (CA) III, CA IV, CA VA, CA VB, CA VI, CA VII, CA IX, CA XII, and CA XIV can be modulated by aloperine in the nitrogen metabolism.

Conclusion.

Our work revealed the pharmacological and molecular mechanisms of aloperine against CVD and provided a feasible tool to identify the pharmacological mechanisms of single active ingredient of traditional Chinese medicines.